News & Updates
November 18, 2025
Distalmotion Raises $150 Million to Accelerate US Expansion of the DEXTER® Robotic Surgery System and Names Chas McKhann as Executive Chairman
October 1, 2025
Distalmotion Secures Third FDA Clearance for DEXTER® with Hysterectomy Indication
August 6, 2025
Distalmotion Marks Patient Enrollment Milestones in General Surgery and Gynecology Clinical Trials for the DEXTER® Robotic Surgery System
June 24, 2025
Distalmotion Achieves Milestone in the US as AdventHealth Acquires Multiple DEXTER® Robotic Surgery Systems
May 28, 2025
Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System
April 22, 2025
Distalmotion Advances US Expansion of its DEXTER® Surgical Robot with Clinical Milestones and System Enhancements
March 27, 2025
Distalmotion Announces Acquisition of its DEXTER® Robotic Surgery System by the First Ambulatory Surgery Center in the US
March 25, 2025
Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System
December 3, 2024
First Patients in US Treated with Distalmotion’s Dexter® Robotic Surgery System in the Outpatient Setting
October 28, 2024
FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Robotic Surgery System